The first medication in this class, sitagliptin, received FDA approval in 2006 for the treatment of type 2 diabetes
Standard and mannitol-free formulations are offered where shown in the variation selector
There are also now two drugs on the market that are FDA-approved for weight loss -- Wegovy, a medication that contains the same main ingredient, semaglutide, as Ozempic, and Zepbound, a medication that contains the same main ingredient, tirzepatide, as Mounjaro
Retatrutide represents the current frontier in incretin pharmacology a single 39-amino-acid synthetic peptide that simultaneously activates three metabolic receptors: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon
Description GLP-3 RT (Retatrutide) 10mg / 3mL Pre-Filled Research Pen contains 10mg of Retatrutide in 3mL of sterile solution